Eurolab is the largest generic oncology company in South Africa and one of the most innovative in cancer treatment, cancer management and cancer care. Headquartered in Johannesburg, South Africa, we provide treatment therapies and technologies for oncologists to offer their patients the best, the latest and the most affordable options for their cancer treatment.

Quality and compliance are the cornerstones of our business. Eurolab drives quality across all its operations.

Our business was founded by two pioneers in South Africa’s pharmaceutical sector who recognised the pressing need to bring down the costs of cancer treatment. The Eurolab Group has grown steadily, continually expanding its whole-of-cancer offering to make more cancer treatment options available to more people at more affordable rates.

Top proffesionals make up our team which includes pharmacists, clinicians, haematologists, clinical pharmacologists, regulatory experts, health systems strengthening experts, marketers, ICT and financial experts, administrators, as well as leading oncologists.

Eurolab is proud to be a South African company, owned by South Africans, employing South Africans, and investing our profits back into the South African economy. We stay abreast of the latest clinical trials that test new treatment regimens for different kinds of cancer and enjoy strong relationships with academic and research institutions in South Africa and internationally.